Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label Phase IIa Study Evaluating the Safety and Efficacy of NE3107 in Improving Sleep and Fatigue in Subjects With Traumatic Brain Injury

NCT05970575 is registered in ClinicalTrials.gov with Neurological Associates of West Los Angeles as lead sponsor.

NCT NCT05970575
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05970575 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label Phase IIa Study Evaluating the Safety and Efficacy of NE3107 in Improving Sleep and Fatigue in Subjects With Traumatic Brain Injury
Lead sponsor
Neurological Associates of West Los Angeles
Phase
Phase 2
Overall status
Terminated
Start date
December 21, 2023
Completion date
July 21, 2025
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

traumatic brain injury